1月13日【中銀做客】恒指、紫金礦業、江西銅業、石藥集團、藥明生物、中國人壽

Market Overview - The Hang Seng Index reached a high of 27,143 points, close to the November high of 27,188 points, but the upward momentum has slowed down [1] - The trading volume in the Hong Kong market was robust, exceeding 276 billion, indicating high market activity [1] - The A-share market also saw increased trading volume, approaching 3.6 trillion, reflecting a similar trend in market enthusiasm [1] Investor Sentiment - After the Hang Seng Index surpassed 27,100 points, some investors became more conservative, opting to lock in profits by selling call warrants and buying put warrants [2] - The market is expected to experience a short-term adjustment around the 27,000-point level, as investors digest the recent rapid gains of nearly 1,000 points in about a week [2] Individual Stocks - Zijin Mining (02899) has shown strong performance, reaching a high of 40.7 HKD, with positive sentiment towards precious metals expected to continue [3] - The international gold price is projected to rise to 5,000 USD per ounce, with current prices around 4,600 USD, indicating a bullish outlook for precious metals [3] - Investors are encouraged to consider leveraged products related to precious metals, such as call warrants for Zijin Mining with a strike price of 48.65 HKD [4] Other Stocks of Interest - Jiangxi Copper (00358) is gaining attention, with a notable increase in street stock volume, indicating growing investor interest [5] - The company derives 20%-30% of its profits from gold, making it a dual-play opportunity for investors [5] - Stone Pharmaceutical (01093) has reached a high of 10 HKD, with potential for further gains as AI applications in pharmaceuticals are expected to enhance profitability [6] - WuXi Biologics (2269) is also benefiting from AI in drug development, with its stock price nearing 40.2 HKD, close to its previous high of 42.6 HKD [7] Insurance Sector - China Life Insurance (02638) has shown impressive performance, nearly doubling in value over the past year, with a current high of 33.18 HKD [8] - The insurance sector is expected to benefit from improved fundamentals and increased market activity, with long-term capital inflows supporting growth [8] - Investors are advised to consider call warrants for China Life with a strike price of 35.02 HKD, which may soon reach the strike price [8]